GlassScriptPhysician profile
Michael S Lepire
NPI 1295786812
$9,134.41
in general payments reported to CMS, 2019-2025
35 companies · $3,451 in 2025
The $3,451 reported for 2025 was more than what 85% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,394 · 2020: $425 · 2021: $364 · 2022: $489 · 2023: $1,226 · 2024: $786 · 2025: $3,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,815 · Education: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,814.70 |
| Education | $647.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noctrix Health, INC. | $2,400.83 | 2025 | Nidra |
| Jazz Pharmaceuticals INC. | $1,857.90 | 2019-2025 | |
| Inspire Medical Systems, INC. | $759.27 | 2020-2025 | Inspire |
| Harmony Biosciences LLC | $661.69 | 2022-2025 | Wakix |
| Actelion Pharmaceuticals US, INC. | $532.05 | 2019-2025 | Opsumit, Uptravi |
| Zoll Respicardia, INC. | $381.98 | 2021-2025 | Remede System |
| Glaxosmithkline, LLC. | $378.58 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $368.59 | 2019-2020 | |
| Genentech USA, INC. | $330.46 | 2019-2020 | |
| Genzyme Corporation | $184.81 | 2019 | |
| Philips North America LLC | $177.44 | 2019-2025 | (6299) Dreamwear, Dreamwear, (Di7) Home Pi Undivided |
| Avadel Cns Pharmaceuticals, LLC | $159.16 | 2023-2025 | Lumryz |
| Alexion Pharmaceuticals, INC. | $120.91 | 2019 | |
| Insmed, INC. | $99.39 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.08 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $77.83 | 2019 | |
| Axsome Therapeutics, INC. | $68.45 | 2024 | Sunosi |
| Scilex Pharmaceuticals INC. | $48.23 | 2019 | |
| Amgen INC. | $39.80 | 2019 | |
| Grifols USA, LLC | $39.46 | 2019 | |
| Sunovion Pharmaceuticals INC. | $35.88 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $31.48 | 2019 | |
| Circassia INC. | $30.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.45 | 2019 | |
| Idorsia Pharmaceuticals US INC | $27.02 | 2022-2023 | Quviviq |
| Boston Scientific Corporation | $25.09 | 2024 | |
| Pulmonx Corporation | $24.91 | 2019 | |
| Abbott Laboratories | $23.73 | 2019 | |
| Pfizer INC. | $21.49 | 2019 | |
| Mylan Specialty L.P. | $21.32 | 2019 | |
| Dexcom, INC. | $18.09 | 2020 | |
| Emergent Biosolutions INC. | $16.91 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.24 | 2019 | |
| 3b Medical, INC. | $14.64 | 2025 | Luna |
| Merck Sharp & Dohme LLC | $13.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lepire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.